D costs
start of ND
incidence of ND
shape of microfluidic chips
Chips Neurodegenerative diseases
drug agencies
biopharmaceutical research
subcategory of Organ
organ subunits
worldwide economic impact of ND
Nerve
years
animal models
offering
human-relevant drug responses
patented NOC technology
clinical research
MicroBrain Biotech
animal testing
Reconstitution of complex organ-level physiological functions
innovative biotech startup
OOC market share
increased efficiency
individual patients
different types of reconstructed neuron networks
relativesthe health care system
biology
improvement patent
society
competitors
cureor
supply chain
organoids
IP policy
purchase of licenses
financial burden
improved competitiveness
tri-dimensional
readouts
micron scale
absence of drugs able
clients
culture systems
advantages
key solutions
real time visualization
independence
life expectancy increases
function of tissues
people
Alzheimer Disease
individuals
memories
biological approach
Compatibility
feasibility study
MBBTâ€™s objective
lives